One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Acknowledging Disparities in Hereditary Cancer Testing.
Sun, Sophie MD 1,; Gelmon, Karen A. MD 1,,
doi : 10.1200/JCO.21.02287
Volume 39(36) pgs. 4001-4128,e1-e8 December 20, 2021
Picture a Professional: Rethinking Expectations of Medical Professionalism Through the Lens of Diversity, Equity, and Inclusion.
Rosenberg, Abby R. MD, MS, MA 1,2,; Jagsi, Reshma MD, DPhil 3,4,; Marron, Jonathan M. MD, MPH 5,6,
doi : 10.1200/JCO.21.01500
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
Fontana, Elisa MD, PhD 1,2,,; Meyers, Jeff PhD 3; Sobrero, Alberto MD 4,; Iveson, Timothy MD 5,; Shields, Anthony F. MD 6,; Taieb, Julien MD 7,; Yoshino, Takayuki MD 8,; Souglakos, Ioannis MD 9,10,; Smyth, Elizabeth C. MD 2,11,; Lordick, Florian MD 2,12,; Moehler, Markus MD 2,13,; Giraut, Anne PhD 14; Harkin, Andrea MD 15; Labianca, Roberto MD 16,; Meyerhardt, Jeffrey MD 17,; Andre, Thierry MD 18,; Boukovinas, Ioannis MD 19,; Lonardi, Sara MD 20,; Saunders, Mark MD 21,; Vernerey, Dewi PhD 22,23,; Oki, Eiji MD 24,; Georgoulias, Vassilis MD 25,; Ben-Aharon, Irit MD 2,26; Shi, Qian PhD 3,
doi : 10.1200/JCO.21.02008
Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
Ademuyiwa, Foluso O. MD, MPH, MSCI 1,,; Salyer, Patricia MEd 2; Tao, Yu MD 3,4; Luo, Jingqin PhD 3,4; Hensing, Whitney L. MD 1; Afolalu, Abisola MD 5; Peterson, Lindsay L. MD, MSCR 1; Weilbaecher, Katherine MD 1; Housten, Ashley J. OTD, MSCI 3; Baumann, Ana A. PhD 6; Desai, Monica MD 7; Jones, Susan MS, CGC 8; Linnenbringer, Erin PhD 3; Plichta, Jennifer MD, MS 9,; Bierut, Laura MD 2
doi : 10.1200/JCO.21.01426
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.
Leavey, Patrick J. MD 1,,; Laack, Nadia N. MD 2,; Krailo, Mark D. PhD 3,; Buxton, Allen MS 4; Randall, R. Lor MD 5,; DuBois, Steven G. MD 6,; Reed, Damon R. MD 7,; Grier, Holcombe E. MD 6; Hawkins, Douglas S. MD 8,; Pawel, Bruce MD 9; Nadel, Helen MD 10,; Womer, Richard B. MD 11; Letson, G. Douglas MD 7,; Bernstein, Mark MD 12,; Brown, Kenneth MD 13; Maciej, Alexis MS 14; Chuba, Paul MD, PhD 15,; Ahmed, Atif A. MD 16; Indelicato, Daniel J. MD 17; Wang, Dian MD 18; Marina, Neyssa MD 19,; Gorlick, Richard MD 20,; Janeway, Katherine A. MD 6,; Mascarenhas, Leo MD 9,
doi : 10.1200/JCO.21.00358
Predicted Cure and Survival Among Transplant Recipients With a Previous Cancer Diagnosis.
Engels, Eric A. MD, MPH 1,; Haber, Gregory PhD 1,; Hart, Allyson MD 2,; Lynch, Charles F. MD 3,; Li, Jie BA 4; Pawlish, Karen S. BA 4; Qiao, Baozhen BA 5; Yu, Kelly J. PhD 1; Pfeiffer, Ruth M. PhD 1
doi : 10.1200/JCO.21.01195
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study.
Al-Sawaf, Othman MD 1,2,3,; Zhang, Can PhD 1; Lu, Tong PhD 4,; Liao, Michael Z. PhD 4,; Panchal, Anesh MSc 5,; Robrecht, Sandra PhD 1; Ching, Travers PhD 6,; Tandon, Maneesh MBChB 5,; Fink, Anna-Maria MD 1,; Tausch, Eugen MD 7,; Schneider, Christof MD 7; Ritgen, Matthias MD 8,; Bottcher, Sebastian MD 9,; Kreuzer, Karl-Anton MD 1,; Chyla, Brenda PhD 10,; Miles, Dale PhD 4,; Wendtner, Clemens-Martin MD 11,; Eichhorst, Barbara MD 1,; Stilgenbauer, Stephan MD 7,12,; Jiang, Yanwen PhD 4,; Hallek, Michael MD 1,; Fischer, Kirsten MD 1,,
doi : 10.1200/JCO.21.01181
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.
Locati, Laura D. MD, PhD 1,,; Cavalieri, Stefano MD 1; Bergamini, Cristiana MD 1; Resteghini, Carlo MD 1,; Colombo, Elena MD 1; Calareso, Giuseppina MD 2; Mariani, Luigi MD 3; Quattrone, Pasquale MD 4; Alfieri, Salvatore MD 1; Bossi, Paolo MD 1,; Platini, Francesca MD, PhD 1; Capone, Iolanda MSc 4; Licitra, Lisa MD 1,5,
doi : 10.1200/JCO.21.00468
Androgen Receptor Pathway in Salivary Gland Cancer.
Ho, Alan L. MD, PhD 1,2,,
doi : 10.1200/JCO.21.01983
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Schneider, Bryan J. MD 1,; Naidoo, Jarushka MD 2,3,; Santomasso, Bianca D. MD, PhD 4,; Lacchetti, Christina MHSc 5; Adkins, Sherry MS 6,; Anadkat, Milan MD 7,; Atkins, Michael B. MD 8,; Brassil, Kelly J. PhD 6,; Caterino, Jeffrey M. MD, MPH 9,; Chau, Ian MD 10,; Davies, Marianne J. DNP 11,; Ernstoff, Marc S. MD 12,; Fecher, Leslie MD 1,; Ghosh, Monalisa MD 13,; Jaiyesimi, Ishmael DO, MS 14; Mammen, Jennifer S. MD, PhD 15,; Naing, Aung MD 6,; Nastoupil, Loretta J. MD 6,; Phillips, Tanyanika MD 16,; Porter, Laura D. MD 17; Reichner, Cristina A. MD 18; Seigel, Carole MBA 19; Song, Jung-Min MSN, RN, CNS 20; Spira, Alexander MD, PhD 21,; Suarez-Almazor, Maria MD 6,; Swami, Umang MD 22,; Thompson, John A. MD 23,; Vikas, Praveen MD 24,; Wang, Yinghong MD 6,; Weber, Jeffrey S. MD, PhD 25,; Funchain, Pauline MD 20,; Bollin, Kathryn MD 26
doi : 10.1200/JCO.21.01440
Reply to J. Wei et al.
Lin, Nancy U. MD; Pegram, Mark MD; Sahebjam, Solmaz MD; Ibrahim, Nuhad MD; Fung, Anita PharmD; Cheng, Anna PharmD; Nicholas, Alan PhD; Kirschbrown, Whitney PharmD, PhD; Kumthekar, Priya MD
doi : 10.1200/JCO.21.01973
